Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Verastem and Merck & Co. to collaborate with Cancer Research UK for cancer immunotherapy research

Oct. 4, 2016

Boehringer Ingelheim and Sarah Cannon Institute enter collaboration for cancer drug development

Oct. 3, 2016

Safety and efficacy of durvalumab in patients with advanced urothelial bladder cancer

Oct. 3, 2016

Daiichi Sankyo to acquire license for technology platforms from Zymeworks

Sep. 30, 2016

Adaptimmune Therapeutics and MD Anderson form cancer immunotherapy alliance

Sep. 30, 2016

Medigene and bluebird bio collaborate on TCR immunotherapies

Sep. 29, 2016

Pronai Therapeutics obtains exclusive license for PNT-737 from the CRT Pioneer Fund

Sep. 29, 2016

NCI awards SBIR contract to Cellerant Therapeutics

Sep. 29, 2016

Actinium Pharmaceuticals starts phase II trial of Actimab-A in patients with AML

Sep. 29, 2016

Beyondspring Pharmaceuticals enrolls first patient in phase Ib/II trial of plinabulin

Sep. 28, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...